Clinical Trials Logo

Endometrioma clinical trials

View clinical trials related to Endometrioma.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06421857 Completed - Endometrioma Clinical Trials

Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

laparoscopic excision of ovarian endometriotic cysts is generally recommended because it has been associated with a higher spontaneous conception rate, residual ovarian function after the procedure may be affected

NCT ID: NCT06274086 Completed - Endometrioma Clinical Trials

Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and clinical outcomes of two-session catheter-directed sclerotherapy (CDS) with 96% ethanol in patients with endometrioma. The main question it aims to answer is: • Is two-session CDS with 96% ethanol safe and effective for treating endometrioma? Participants will: - Receive the first session CDS for endometrioma - Carry the catheter overnight and be monitored in the patient ward - Receive the second session CDS the next day

NCT ID: NCT06219044 Completed - Endometrioma Clinical Trials

Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization

OMAlaser
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

PURPOSE OF THE STUDY The study aims to evaluate the effectiveness of the Dual Wavelength Laser System (DWLS) diode laser on the treatment of endometrioma (OMA), with ablation and vaporization of the cystic capsule without performing the stripping technique, in terms of ovarian reserve and recurrence rate.

NCT ID: NCT05348070 Completed - Endometrioma Clinical Trials

Comparison of Operated Ruptured and Non-ruptured Endometriomas

RupturedOMA
Start date: January 1, 2014
Phase:
Study type: Observational

Ruptured endometrioma cases were compared with unruptured endometrioma cases.

NCT ID: NCT05323539 Completed - Thyroid Clinical Trials

Comparison of Thyroid Volumes in Patients With and Without Endometrioma

Start date: September 20, 2021
Phase: N/A
Study type: Interventional

The aim of our study is to evaluate whether there is a statistical difference between thyroid gland volume in patients with pathological diagnosis of endometriosis or endometrioma and in patients who underwent surgery for other gynecological reasons, and to reveal the presence of concomitant thyroid disease in these cases.

NCT ID: NCT04941833 Completed - Endometrioma Clinical Trials

Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo

Start date: June 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma in the patient who underwent to surgery in next 3 months The result will be evaluated on cyst diameter, the associated pain and side effect of the oral desogestrel.

NCT ID: NCT04371133 Completed - Inflammation Clinical Trials

Anti-inflammatory Markers in Endometrioma

Start date: August 15, 2018
Phase:
Study type: Observational

Investigators aimed to measure the serum levels of adropin, salusin-α, netrin-1, and nesfatin-1, anti-inflammatory effects of which have been demonstrated previously, in endometriosis patients and to find out any association of them with insulin resistance.

NCT ID: NCT03484546 Completed - Endometriosis Clinical Trials

Optimum Menstrual Cycle Time for Endometrioma Excision

Start date: March 26, 2018
Phase:
Study type: Observational

This study evaluates the optimum day of menstrual period for the excision of endometriomas to minimize the damage of surgery to normal ovarian tissue. Patients will be grouped as follicular, ovulatory and luteal according to menstrual days. Ovarian damage will be evaluated with both pathologic examination and anti-mullerian hormone levels before and after the surgery.

NCT ID: NCT02947724 Completed - Endometrioma Clinical Trials

Surgicel Reduces Ovarian Endometriomas Recurrence

Start date: January 2016
Phase: Phase 2
Study type: Interventional

Two hundred women aged from 20 to 35 years undergoing conservative laparoscopic treatment of ovarian endometriomas (either by drainage or cyst wall excision) were included. Participants were randomized into 4 groups; group A (drainage only) in which 50 patients underwent laparoscopic fenestration and electrocautery of the endometrioma cyst wall, group B (cystectomy only) in which 50 patients underwent laparoscopic excision of the endometrioma cyst wall, group C (drainage & Surgicel) in which 50 patients underwent laparoscopic fenestration of the endometrioma cyst wall followed by insertion of 4 pieces of Surgicel inside the cyst cavity, group D (cystectomy & Surgicel) in which 50 patients underwent laparoscopic excision of the endometrioma cyst wall followed by insertion of 4 pieces of Surgicel inside the remaining ovarian tissues.All patients were followed up every 3 months for 2 years following the laparoscopic surgery. The primary outcome was the recurrence of endometriomas in the ipsilateral ovary (recurrence was defined as the presence of ovarian cysts with the characteristic sonographic features of endometriomas (≥1 cm). The ovarian reserve was reassessed (AMH & day 2 AFC) as a secondary outcome 6 months following the laparoscopy.

NCT ID: NCT02737800 Completed - Endometrioma Clinical Trials

Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients

GnRh
Start date: April 2016
Phase: N/A
Study type: Interventional

Investigators compare ICSI results for endometrioma patients with or without cyst aspiration if more than 5cm &with or without GnRh agonists for all endometrioma patients